NEW YORK, Dec. 17, 2015 /PRNewswire/ -- This BCC Research report provides the reader with a detailed analysis of the global infectious disease market, with emphasis on seven major infectious diseases (i.e., human immunodeficiency virus/acquired immunodeficiency virus [HIV/AIDS]; hepatitis A, B, C; malaria, rotavirus/diarrhea; measles; pneumonia; and tuberculosis [TB]). Includes forecasts from 2016-2021.
Use this report to:
Assess the current state of infectious diseases on a global basis.
Identify the driving factors for demand of new diagnostic and pharmaceutical products.
Estimate current and future market sizes for diagnostic, vaccine, and pharmaceutical infectious disease products.
Estimate the current global supply-and-demand scenario, by disease type and geographical region.
The global market for infectious disease diagnostic, vaccine, and pharmaceutical treatment products reached $108.4 billion in 2015. The market should reach $126.2 billion in 2016 and $183.2 billion in 2021, demonstrating a compound annual growth rate (CAGR) of 7.7% from 2016 to 2021.
Pharmaceutical treatments make up the fastest-growing segment of the market totaling $65.4 billion in 2015 and an estimated $78.3 billion in 2016. The market segment should grow at a CAGR of 8.8%, leading to a projected total of $119.3 billion by 2021.
The vaccine market for infectious diseases totaled $25.2 billion in 2015. The market should reach $28.5 billion in 2016 and $39.7 billion in 2021, a CAGR of 6.8%.
STUDY GOALS AND OBJECTIVES
Infectious diseases are one of the major causes of global morbidity and mortality. Viral, bacterial, parasitic and fungal diseases have plagued humankind for centuries, and our attempts to control these diseases have met with great success. Diseases that were once death sentences are now either virtually eliminated or have become chronic, manageable diseases.
However, as with every ongoing story, microbes have transformed themselves to outwit current medications, and the battle to rid humans of the most virulent of diseases continues. With the constant combining and reinvention of microbes comes an urgent need for improved antibiotic and viral medications to sustain the progress made in addressing the most aggressive of infectious diseases.
Under these circumstances, there is need for a current and comprehensive report on infectious diseases covering diagnosis, treatment, demand trends, opportunities and emerging technologies.
This study gives a clear, quantitative picture of the supply-and-demand scenario, and it highlights the echnological and investment opportunities in the field.
Read the full report: http://www.reportlinker.com/p01187982-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001